Hyperthermia and Early Growth of Cerebral Infarct: The Potential Role of Blood–Brain Barrier Permeability
Hyperthermia within the first 24 h following ischemic stroke (IS) has been associated with poor outcomes. We sought to determine whether blood-brain barrier (BBB) permeability contributes to the relationship between hyperthermia and early infarct growth (EIG). A retrospective analysis was conducted on a prospective stroke biobank. EIG was defined as the percentage difference between the initial volume (mL) determined by the diffusion-weighted imaging at admission and the volume (mL) from the control CT image on the 4 th-7 th day. Hyperthermia was defined as an axillary body temperature ≥ 37.5 °C within the first 24 h. Soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) serum levels were measured by ELISA. One-hundred and two (19.7%) patients showed EIG from a cohort of 519 patients (45.6% females). Linear correlation was observed for axillar body temperature and EIG (Pearson's r = 0.46; p < 0.001). sTWEAK serum levels showed a c-statistic of 0.74 (95% CI: 0.69-0.79), with an optimal cut-off point > 3000 pg/mL for EIG prediction. Moreover, microalbuminuria levels strongly correlated with sTWEAK levels (Pearson's r = 0.75; p < 0.001). In the multivariate analysis for EIG was observed an independent association with hyperthermia (adjusted OR 24.21; 95% CI: 12.03-39.12), sTWEAK levels > 3000 pg/mL (adjusted OR 16.43; 95% CI: 3.71-72.70), leukoaraiosis (adjusted OR 10.42; 95% CI: 2.68-39.08), and microalbuminuria (adjusted OR 1.02; 95% CI: 1.00-1.12). In our cohort, hyperthermia was independently associated with EIG after IS. The fact that microalbuminuria, leukoaraiosis, and sTWEAK were also associated with EIG suggests a relationship with increased BBB permeability.
Authors
- Sabela Fernández‐Rodicio (ORCID: https://orcid.org/0009-0003-2381-6432)
- Antonio J. Mosqueira (ORCID: https://orcid.org/0000-0003-0345-2486)
- Manuel Rodríguez‐Yáñez (ORCID: https://orcid.org/0000-0002-5381-8557)
- Arturo González‐Quintela (ORCID: https://orcid.org/0000-0002-6909-1807)
- Jacobo Porto-Álvarez (ORCID: https://orcid.org/0000-0002-1646-0680)
- Pablo Hervella (ORCID: https://orcid.org/0000-0003-1249-6333)
- Tomás Sobrino (ORCID: https://orcid.org/0000-0002-9760-8690)
- Marcos Bazarra‐Barreiros (ORCID: https://orcid.org/0000-0003-1317-6745)
- Crhistian‐Mario Oblitas (ORCID: https://orcid.org/0000-0002-4731-749X)
- Ramón Iglesias‐Rey (ORCID: https://orcid.org/0000-0002-9985-9135)
- María Luz Alonso-Alonso (ORCID: https://orcid.org/0000-0003-2603-5271)
- Francisco Campos Freire (ORCID: https://orcid.org/0000-0003-1831-1838)
- Iria López‐Dequidt (ORCID: https://orcid.org/0000-0002-3558-9295)
- José Castillo (ORCID: https://orcid.org/0000-0002-6685-3001)
- Alberto Ouro (ORCID: https://orcid.org/0000-0003-4359-1704)
- Ana Sampedro‐Viana (ORCID: https://orcid.org/0000-0002-8482-3893)
- Sara Ortega-Espina
- María Teresa Abengoza-Bello
- Javier Martínez Fernández (ORCID: https://orcid.org/0009-0005-6166-9351)
Institutions
- Universidade de Santiago de Compostela (ES)
- Instituto de Salud Carlos III (ES)
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Complejo Hospitalario Universitario de Santiago (ES)
- Centro de Investigación Biomédica en Red (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Instituto de Investigación Sanitaria de Santiago (ES)
- Instituto de Investigación de Enfermedades Raras (ES)
- Complejo Hospitalario Universitario de Ferrol (ES)
Publication Details
- Journal
- Translational Stroke Research
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1007/s12975-025-01349-x
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministerio de Ciencia e Innovación
- Xunta de Galicia
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- Instituto de Salud Carlos III
- European Regional Development Fund